Clinical Trials
24 trialsCAOS
IRCCS San Raffaele
RithMM
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
ASCOLT
National Cancer Centre, Singapore
The Colorectal Cancer Chemoprevention Acceleration and Improvement Platform (CRC-CHAMP) Study
University of Calgary
ACES
Hennepin Healthcare Research Institute
Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC)
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Prophylactic Anticoagulation for Catheter-related Thrombosis
Second Affiliated Hospital, School of Medicine, Zhejiang University
Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex
Peking Union Medical College Hospital
Outcome Analysis of Aspirin in Liver Transplantation
University of Zurich
Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery
Fudan University
Preventive Effects of Aspirin as Adjuvant Therapy in Patients With Locally Advanced Renal Cell Carcinoma
RenJi Hospital
Breast Cancer Active Surveillance, Alternative Option, Aspirin Included
Centro Hospitalar Lisboa Ocidental
Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients
Sun Yat-sen University
Efficiency Study of Aspirin to Prevent the Occurrence of Prostate Cancer
West China Hospital
APREMEC
The Fourth Affiliated Hospital of Anhui Medical University
ACABC
Zhejiang Provincial People's Hospital
Gefitinib Combined With Thalidomide to Treat NSCLC
Shaanxi Provincial People's Hospital
Acetylsalicylic Acid and Colorectal Cancer Prevention: Exploring the Platelet Function of Its Mechanism of Action
Aragon Institute of Health Sciences
Aspirin and/or Folic Acid in Preventing Recurrent Colorectal Polyps
National Cancer Institute (NCI)
Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer
ChineseAMS
Physiological Effects of Altering Cancer-related Inflammation
NHS Greater Glasgow and Clyde
Low Dose Chemotherapy With Aspirin in Patients With Breast Cancer After Neoadjuvant Chemotherapy
University of Vermont
ASAPOL
Maria Sklodowska-Curie National Research Institute of Oncology
CREAT
Beijing Friendship Hospital